Literature DB >> 26929217

Evidence for Differential Glycosylation of Trophoblast Cell Types.

Qiushi Chen1, Poh-Choo Pang1, Marie E Cohen2, Mark S Longtine3, Danny J Schust4, Stuart M Haslam1, Sandra M Blois5, Anne Dell6, Gary F Clark7.   

Abstract

Human placental villi are surfaced by the syncytiotrophoblast (STB), with a layer of cytotrophoblasts (CTB) positioned just beneath the STB. STB in normal term pregnancies is exposed to maternal immune cells in the placental intervillous space. Extravillous cytotrophoblasts (EVT) invade the decidua and spiral arteries, where they act in conjunction with natural killer (NK) cells to convert the spiral arteries into flaccid conduits for maternal blood that support a 3-4 fold increase in the rate of maternal blood flow into the placental intervillous space. The functional roles of these distinct trophoblast subtypes during pregnancy suggested that they could be differentially glycosylated. Glycomic analysis of these trophoblasts has revealed the expression of elevated levels of biantennary N-glycans in STB and CTB, with the majority of them bearing a bisecting GlcNAc. N-glycans terminated with polylactosamine extensions were also detected at low levels. A subset of the N-glycans linked to these trophoblasts were sialylated, primarily with terminal NeuAcα2-3Gal sequences. EVT were decorated with the same N-glycans as STB and CTB, except in different proportions. The level of bisecting type N-glycans was reduced, but the level of N-glycans decorated with polylactosamine sequences were substantially elevated compared with the other types of trophoblasts. The level of triantennary and tetraantennary N-glycans was also elevated in EVT. The sialylated N-glycans derived from EVT were completely susceptible to an α2-3 specific neuraminidase (sialidase S). The possibility exists that the N-glycans associated with these different trophoblast subpopulations could act as functional groups. These potential relationships will be considered.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26929217      PMCID: PMC5083094          DOI: 10.1074/mcp.M115.055798

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  49 in total

1.  Tumor-released Galectin-3, a soluble inhibitory ligand of human NKp30, plays an important role in tumor escape from NK cell attack.

Authors:  Wei Wang; Huaijian Guo; Jianlin Geng; Xiaodong Zheng; Haiming Wei; Rui Sun; Zhigang Tian
Journal:  J Biol Chem       Date:  2014-10-14       Impact factor: 5.157

2.  Expression of HLA class I molecules in human first trimester and term placenta trophoblast.

Authors:  H Hutter; A Hammer; A Blaschitz; M Hartmann; P Ebbesen; G Dohr; A Ziegler; B Uchanska-Ziegler
Journal:  Cell Tissue Res       Date:  1996-12       Impact factor: 5.249

3.  Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae.

Authors:  H J Kliman; J E Nestler; E Sermasi; J M Sanger; J F Strauss
Journal:  Endocrinology       Date:  1986-04       Impact factor: 4.736

4.  Early human decidual cells exhibit NK activity against the K562 cell line but not against first trimester trophoblast.

Authors:  A King; C Birkby; Y W Loke
Journal:  Cell Immunol       Date:  1989-02       Impact factor: 4.868

Review 5.  Galectins: guardians of eutherian pregnancy at the maternal-fetal interface.

Authors:  Nandor Gabor Than; Roberto Romero; Chong Jai Kim; Michael R McGowen; Zoltan Papp; Derek E Wildman
Journal:  Trends Endocrinol Metab       Date:  2011-10-27       Impact factor: 12.015

6.  Hypoxia downregulates p53 but induces apoptosis and enhances expression of BAD in cultures of human syncytiotrophoblasts.

Authors:  Baosheng Chen; Mark S Longtine; Yoel Sadovsky; D Michael Nelson
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-01       Impact factor: 4.249

7.  Stimulation of syncytium formation in vitro in human trophoblast cells by galectin-1.

Authors:  I Fischer; S Redel; S Hofmann; C Kuhn; K Friese; H Walzel; U Jeschke
Journal:  Placenta       Date:  2010-07-24       Impact factor: 3.481

8.  Potent suppression of natural killer cell response mediated by the ovarian tumor marker CA125.

Authors:  Manish S Patankar; Yu Jing; Jamie C Morrison; Jennifer A Belisle; Frank A Lattanzio; Yuping Deng; Nyet Kui Wong; Howard R Morris; Anne Dell; Gary F Clark
Journal:  Gynecol Oncol       Date:  2005-08-29       Impact factor: 5.482

9.  Thermodynamics of carbohydrate binding to galectin-1 from Chinese hamster ovary cells and two mutants. A comparison with four galactose-specific plant lectins.

Authors:  D Gupta; M Cho; R D Cummings; C F Brewer
Journal:  Biochemistry       Date:  1996-12-03       Impact factor: 3.162

10.  Suppression by human placental protein 14 of natural killer cell activity.

Authors:  N Okamoto; A Uchida; K Takakura; Y Kariya; H Kanzaki; L Riittinen; R Koistinen; M Seppälä; T Mori
Journal:  Am J Reprod Immunol       Date:  1991-12       Impact factor: 3.886

View more
  12 in total

1.  Establishment of fetomaternal tolerance through glycan-mediated B cell suppression.

Authors:  G Rizzuto; J F Brooks; S T Tuomivaara; T I McIntyre; S Ma; D Rideaux; J Zikherman; S J Fisher; A Erlebacher
Journal:  Nature       Date:  2022-03-02       Impact factor: 69.504

2.  Glycan characterization of pregnancy-specific glycoprotein 1 and its identification as a novel Galectin-1 ligand.

Authors:  Mirian Mendoza; Dongli Lu; Angela Ballesteros; Sandra M Blois; Kelsey Abernathy; Chiguang Feng; Charles J Dimitroff; Jonathan Zmuda; Maria Panico; Anne Dell; Gerardo R Vasta; Stuart M Haslam; Gabriela Dveksler
Journal:  Glycobiology       Date:  2020-10-21       Impact factor: 4.313

3.  Galectin-1 interacts with the human endogenous retroviral envelope protein syncytin-2 and potentiates trophoblast fusion in humans.

Authors:  Caroline Toudic; Amandine Vargas; Yong Xiao; Guillaume St-Pierre; Norbert Bannert; Julie Lafond; Éric Rassart; Sachiko Sato; Benoit Barbeau
Journal:  FASEB J       Date:  2019-09-07       Impact factor: 5.191

4.  Sialic acid is a critical fetal defense against maternal complement attack.

Authors:  Markus Abeln; Iris Albers; Ulrike Peters-Bernard; Kerstin Flächsig-Schulz; Elina Kats; Andreas Kispert; Stephen Tomlinson; Rita Gerardy-Schahn; Anja Münster-Kühnel; Birgit Weinhold
Journal:  J Clin Invest       Date:  2018-12-10       Impact factor: 14.808

Review 5.  The Essential Functions and Detection of Bisecting GlcNAc in Cell Biology.

Authors:  Qiushi Chen; Zengqi Tan; Feng Guan; Yan Ren
Journal:  Front Chem       Date:  2020-07-03       Impact factor: 5.221

6.  Human trophoblast requires galectin-3 for cell migration and invasion.

Authors:  Ž Bojić-Trbojević; M Jovanović Krivokuća; A Vilotić; N Kolundžić; I Stefanoska; F Zetterberg; U J Nilsson; H Leffler; Lj Vićovac
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

Review 7.  Pregnancy Galectinology: Insights Into a Complex Network of Glycan Binding Proteins.

Authors:  Sandra M Blois; Gabriela Dveksler; Gerardo R Vasta; Nancy Freitag; Véronique Blanchard; Gabriela Barrientos
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

8.  An automated platform for the enzyme-mediated assembly of complex oligosaccharides.

Authors:  Tiehai Li; Lin Liu; Na Wei; Jeong-Yeh Yang; Digantkumar G Chapla; Kelley W Moremen; Geert-Jan Boons
Journal:  Nat Chem       Date:  2019-02-21       Impact factor: 24.427

9.  Altered Glycosylation Contributes to Placental Dysfunction Upon Early Disruption of the NK Cell-DC Dynamics.

Authors:  Sophia Borowski; Irene Tirado-Gonzalez; Nancy Freitag; Mariana G Garcia; Gabriela Barrientos; Sandra M Blois
Journal:  Front Immunol       Date:  2020-07-14       Impact factor: 7.561

10.  Insights into the hyperglycosylation of human chorionic gonadotropin revealed by glycomics analysis.

Authors:  Linda Ibeto; Aristotelis Antonopoulos; Paola Grassi; Poh-Choo Pang; Maria Panico; Shabnam Bobdiwala; Maya Al-Memar; Paul Davis; Mark Davis; Julian Norman Taylor; Paula Almeida; Mark R Johnson; Richard Harvey; Tom Bourne; Michael Seckl; Gary Clark; Stuart M Haslam; Anne Dell
Journal:  PLoS One       Date:  2020-02-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.